A gene therapy that helped restore sight in patients with a rare form of childhood blindness appears to wane with time, a sign the cutting-edge field may not be able to cure some ailments with a single course of treatment. Eric A. Pierce, Solman and Libe Friedman Associate Professor of Ophthalmology at Massachusetts Eye and Ear, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?